Basal cell carcinoma epidemiology and demographics
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma epidemiology and demographics |
|
Basal cell carcinoma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Basal cell carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.
Overview
The annual incidence of basal cell carcinoma in the United States is approximately 800-1000 cases per 100,000 individuals. The incidence increases with age and is higher among men. BCC is most common in the Caucasian race.
Epidemiology and Demographics
Incidence
- The annual incidence of basal cell carcinoma in the United States is approximately 2.8 million.[1]
Age
- The incidence of BCC increases with age
- Individuals aged 55 to 75 years have about a 100-fold higher incidence of BCC compared with individuals younger than 20 years of age[2]
Gender
- The incidence of BCC is approximately 30% higher among men than among women (particularly with the superficial type)[3][4][5]
Race
- Basal cell carcinoma is common among the Caucasian race, and rare among individuals of African American race and other darker-skinned populations[6]
Developed and Developing Countries
- States closer to the equator, such as Hawaii and California, have a higher incidence of BCC compared to midwestern states[5][7]
- An increasing incidence over time has also been noted in other countries, such as Canada, Finland, and Australia[3][8][9]
- Basal cell carcinoma (BCC) is the most common skin cancer among the Far-east Asian race[10]
- Majority of Far-east Asian race are Chinese (44.2%), Malays (32.6%), Bidayuhs (14.0%), and Ibans (6.9%)[10]
References
- ↑ Mohan SV, Chang AL (2014). "Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations". Curr Dermatol Rep. 3: 40–45. doi:10.1007/s13671-014-0069-y. PMC 3931971. PMID 24587976.
- ↑ Scotto J, Fears TR, Fraumeni JF Jr, et al. Incidence of nonmelanoma skin cancer in the United States in collaboration with Fred Hutchinson Cancer Research Center. NIH publication No. 83-2433, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 1983:xv. p.11
- ↑ 3.0 3.1 Hannuksela-Svahn A, Pukkala E, Karvonen J (1999). "Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995". Arch Dermatol. 135 (7): 781–6. PMID 10411152.
- ↑ Green A, Battistutta D, Hart V, Leslie D, Weedon D (1996). "Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group". Am J Epidemiol. 144 (11): 1034–40. PMID 8942434.
- ↑ 5.0 5.1 Chuang TY, Popescu A, Su WP, Chute CG (1990). "Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota". J Am Acad Dermatol. 22 (3): 413–7. PMID 2312827.
- ↑ American Cancer Society. Cancer facts and figures 2000. www.cancer.org.2001 (Accessed on March 08, 2005)
- ↑ Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER (1993). "Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States". J Am Acad Dermatol. 29 (2 Pt 1): 184–9. PMID 8335736.
- ↑ Marks R, Staples M, Giles GG (1993). "Trends in non-melanocytic skin cancer treated in Australia: the second national survey". Int J Cancer. 53 (4): 585–90. PMID 8436431.
- ↑ Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV (2005). "Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population". J Am Acad Dermatol. 53 (2): 320–8. doi:10.1016/j.jaad.2005.03.043. PMID 16021129.
- ↑ 10.0 10.1 Yap FB (2010). "Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia". Int J Dermatol. 49 (2): 176–9. doi:10.1111/j.1365-4632.2009.04342.x. PMID 20465642.